HeartSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Market Cap	9	6	4	6	9	-
Market Cap Growth	23.80%	58.28%	-37.17%	-30.38%	-	-
Enterprise Value	10.78	8.5	5.82	1.48	8.89	0
Last Close Price	2.18	1.95	3.51	9.24	88.75	-
PS Ratio	1968.25	1439.53	903.00	336.12	1743.70	-
PB Ratio	30.87	27.50	19.15	0.85	38.95	-
P/TBV Ratio	-	-	-	0.57	12.78	-
EV/Sales Ratio	2496.12	1967.61	1336.91	79.61	1725.41	-
Debt / Equity Ratio	16.80	16.80	13.97	0.13	6.66	-1.00
Net Debt / Equity Ratio	10.09	10.09	9.20	-0.65	-0.41	-0.87
Net Debt / EBITDA Ratio	-0.27	-0.27	-0.23	0.76	0.02	-1.12
Net Debt / FCF Ratio	-0.31	-0.31	-0.25	0.78	0.02	-1.44
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.01
Inventory Turnover	0.00	0.00	0.00	0.01	0.00	0.01
Quick Ratio	0.34	0.34	0.30	3.32	0.91	0.27
Current Ratio	0.53	0.53	0.59	4.20	1.47	0.56
Return on Equity (ROE)	-414.74%	-4239.90%	-233.04%	-175.02%	218.16%	121.23%
Return on Assets (ROA)	-149.44%	-177.38%	-121.70%	-98.60%	-227.39%	-234.48%
Return on Invested Capital (ROIC)	-176.21%	-150.73%	-223.52%	-325.74%	-407.57%	-354.53%
Return on Capital Employed (ROCE)	-348.27%	-1826.38%	-201.97%	-137.00%	-16697.30%	1659.67%
Buyback Yield / Dilution	-179.82%	-179.82%	-166.16%	-962.16%	0.00%	-0.15%
Total Shareholder Return	-179.82%	-179.82%	-166.16%	-962.16%	0.00%	-0.15%

SEC Filings: 10-K · 10-Q